TheEdgeResearch
Home / Stocks / GENH

Generation Hemp, Inc. (GENH)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.22 ▲ +0.00%
Market Cap
$25.3M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.17
52-Wk Range
0.172-0.6
CEO
Gary C. Evans
Country
US
Currency
USD

Generation Hemp, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Dallas, TX, US. The stock last traded at $0.22, up 0.00% on the session, giving a market capitalisation of $25.3M. On trailing twelve-month figures it carries a trailing P/E of -3.88, a net margin of -251.6%. Its beta of 1.17 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-3.88
Price / Sales
9.76
Price / Book
-21.13
EV / EBITDA
-5.70
Gross margin
60.8%
Operating margin
-252.5%
Net margin
-251.6%
Return on equity
Debt / equity
-3.11
Current ratio
0.16
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
11
IPO date
2019-12-24
Headquarters
Dallas, TX, US
About Generation Hemp, Inc.

Generation Hemp, Inc. offers essential post-harvest and midstream services to hemp cultivators. This includes the drying, processing, cleaning, and fiber stripping of raw hemp bales gathered directly from the field. Furthermore, the company maintains ownership of, and leases out, industrial warehouse facilities in Denver. Its corporate headquarters are located in Dallas, Texas.

Comparable companies

Generation Hemp, Inc. is most often compared with the following Healthcare names:

ATHJFBFFTFCHBRFGRAMFHPSTIMMPFKBBTFMKEAFPMXSFVNNYF
More research on GENH
GENH technical analysis GENH TheEdge Score Compare against peers
Open full interactive analysis & DCF →